Tilray Brands, Inc.
Tilray Brands, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 205 | 247 | 265 | 222 | - | 190 | 205 | 228 | 146 | 143 | 178 | 207 | |||||
Restricted Cash Current | - | - | - | - | - | - | - | - | - | 2 | 2 | - | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 45 | - | - | - | - | - | - | - | - | - | - | - | |||||
Marketable Securities Current | 15 | 45 | 0 | 35 | - | 63 | 75 | 32 | 80 | 116 | 287 | 242 | |||||
Accounts Receivable Net Current | 118 | 109 | 107 | 121 | - | 113 | 104 | 102 | 90 | 91 | 82 | 86 | |||||
Inventory Net | 292 | 283 | 283 | 271 | 263 | 266 | 264 | 252 | 244 | 253 | 232 | 201 | |||||
Prepaid Expense And Other Assets Current | 41 | 41 | 41 | 34 | - | 45 | 45 | 31 | 43 | 37 | 45 | 38 | |||||
Land Available For Sale | - | - | - | - | - | - | - | - | 29 | 1 | 4 | - | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | 2 | 4 | 6 | 6 | - | 31 | 33 | 32 | - | - | - | 0 | |||||
Assets Current | 719 | 729 | 701 | 689 | - | 707 | 726 | 678 | 631 | 642 | 829 | 773 | |||||
Property Plant And Equipment And Finance Lease Rig… | 543 | 550 | 560 | 568 | 538 | 554 | 555 | 558 | 579 | 615 | 495 | 430 | |||||
Operating Lease Right Of Use Asset | 18 | 20 | 21 | 22 | 17 | 18 | 17 | 16 | 17 | 14 | 6 | 6 | |||||
Crypto Asset Fair Value Noncurrent | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 23 | 22 | 25 | 21 | 847 | 867 | 909 | 915 | 930 | 953 | 968 | 974 | |||||
Goodwill | 752 | 752 | 752 | 752 | 1,300 | 2,001 | 2,010 | 2,009 | 2,010 | 2,010 | 2,010 | 2,009 | |||||
Other Long Term Investments | - | 13 | 10 | 10 | - | 7 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Equity Method Investments | - | - | - | - | - | - | - | 0 | 0 | 5 | 5 | 5 | |||||
Notes And Loans Receivable Net Noncurrent | - | - | - | 0 | 0 | 32 | 32 | 32 | 32 | 75 | 75 | 103 | |||||
Long Term Investments | 8 | - | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 11 | 11 | 12 | 11 | - | 5 | 5 | 5 | 6 | 9 | 9 | 0 | |||||
Assets | 2,075 | 2,099 | 2,083 | 2,074 | - | 4,192 | 4,262 | 4,222 | 4,213 | 4,331 | 4,402 | 4,307 | |||||
Liabilities Current | |||||||||||||||||
Short Term Borrowings | 9 | 9 | 8 | 7 | - | 18 | 18 | 18 | 15 | 20 | 15 | 23 | |||||
Accounts Payable And Accrued Liabilities Current | 224 | 226 | 231 | 235 | 217 | 222 | 236 | 242 | 210 | 217 | 238 | 191 | |||||
Business Combination Contingent Consideration Liab… | 0 | 0 | 0 | 15 | - | 15 | 15 | 15 | 0 | 8 | 7 | 16 | |||||
Derivative Liabilities Current | 0 | 0 | 5 | 1 | - | 2 | 3 | 3 | 3 | 4 | 10 | 2 | |||||
Secured Debt Current | 17 | 17 | 16 | 15 | - | 16 | 16 | 16 | 12 | 13 | 13 | 24 | |||||
Convertible Debt Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 83 | 128 | 252 | 174 | |||||
Liabilities Current | 258 | 259 | 268 | 280 | - | 279 | 294 | 299 | 329 | 395 | 537 | 433 | |||||
Liabilities Noncurrent | |||||||||||||||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | 0 | 14 | 13 | 13 | 11 | |||||
Secured Long Term Debt | 135 | 139 | 144 | 148 | - | 149 | 155 | 158 | 166 | 169 | 152 | 137 | |||||
Convertible Debt Noncurrent | 88 | 86 | 84 | 86 | 104 | 123 | 133 | 130 | 127 | 124 | 121 | 221 | |||||
Deferred Income Tax Liabilities Net | 8 | 6 | 2 | 4 | - | 126 | 136 | 131 | 161 | 166 | 170 | 167 | |||||
Other Liabilities Noncurrent | 0 | 0 | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 549 | 552 | 562 | 585 | - | 738 | 778 | 778 | 870 | 937 | 1,001 | 977 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Treasury Stock Common Value | 0 | 0 | 0 | 0 | - | 0 | - | 0 | - | - | - | - | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 6,521 | 6,511 | 6,431 | 6,402 | - | 6,306 | 6,218 | 6,147 | 6,031 | 5,943 | 5,910 | 5,778 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -44 | -39 | -43 | -43 | - | -48 | -40 | -43 | -43 | -38 | -44 | -47 | |||||
Retained Earnings Accumulated Deficit | -4,919 | -4,892 | -4,848 | -4,847 | - | -2,785 | -2,700 | -2,660 | -2,629 | -2,536 | -2,487 | -2,416 | |||||
Stockholders Equity | 1,557 | 1,580 | 1,541 | 1,490 | 2,702 | 3,473 | 3,478 | 3,443 | 3,359 | 3,393 | 3,402 | 3,316 | |||||
Minority Interest | -32 | -33 | -20 | -22 | - | -19 | 5 | 0 | -16 | 25 | 22 | 14 | |||||
Liabilities And Stockholders Equity | 2,075 | 2,099 | 2,083 | 2,074 | - | 4,192 | 4,262 | 4,222 | 4,213 | 4,331 | 4,402 | 4,307 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 1,416 | 1,416 | 1,416 | 1,416 | 1,416 | 1,198 | 1,198 | 1,416 | 1,198 | 1,198 | 980 | 980 | |||||
Common Stock Shares Issued | 117 | 117 | 112 | 106 | 98 | 93 | 88 | 83 | 77 | 73 | 72 | 66 | |||||
Shares Outstanding | 1,165 | 1,049 | 1,118 | 1,061 | 983 | 929 | 832 | 832 | 774 | 733 | 723 | 657 | |||||
Treasury Stock Common Shares | 0 | 0 | 3 | 2 | 10 | 4 | - | 0 | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -36.19% | -61.43% | -54.29% | -18.29% | -13.80% | -30.78% | 9.93% | -13.84% | -22.96% | - | - | - |
| 2025 | 3.14% | -15.72% | -10.06% | -14.63% | -39.84% | -46.34% | 0.00% | -6.52% | -13.04% | 98.28% | 108.62% | 168.97% |
| 2024 | -22.97% | -18.92% | -1.35% | -10.90% | -18.01% | 17.06% | 1.94% | -12.62% | -19.42% | -3.98% | -14.43% | -20.90% |
| 2023 | - | - | - | - | - | - | 1.09% | -37.23% | -43.07% | 36.79% | 51.81% | 4.15% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.79 | 2.81 | 2.62 | 2.46 | - | 2.54 | 2.47 | 2.27 | 1.92 | 1.63 | 1.54 | 1.79 | |||||
| Quick Ratio | 1.50 | 1.56 | 1.41 | 1.37 | - | 1.42 | 1.42 | 1.32 | 1.05 | 0.89 | 1.03 | 1.24 | |||||
| Working Capital | 461.22M | 470.00M | 433.51M | 408.32M | - | 428.82M | 432.33M | 378.54M | 302.11M | 247.04M | 291.98M | 340.05M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.35 | 0.35 | 0.36 | 0.39 | - | 0.21 | 0.22 | 0.23 | 0.26 | 0.28 | 0.29 | 0.29 | |||||
| Interest Coverage TTM | -70.98 | -91.10 | -83.71 | -76.21 | -24.13 | -4.99 | -4.86 | -4.80 | -7.76 | -55.97 | -72.75 | -100.81 | |||||
| Debt Ratio | 0.26 | 0.26 | 0.27 | 0.28 | - | 0.18 | 0.18 | 0.18 | 0.21 | 0.22 | 0.23 | 0.23 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.41 | 0.27 | 0.26 | 0.26 | - | 0.19 | 0.19 | 0.19 | 0.17 | 0.14 | 0.13 | 0.13 | |||||
| Days Sales Outstanding TTM | 50.34 | 48.34 | 46.38 | 49.59 | - | 44.75 | 41.83 | 43.47 | 41.22 | 46.97 | 50.59 | 52.82 | |||||
| Receivables Turnover TTM | 7.25 | 7.55 | 7.87 | 7.36 | - | 8.16 | 8.73 | 8.40 | 8.85 | 7.77 | 7.21 | 6.91 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -11.91 | -19.09 | -20.25 | -24.50 | -10.26 | -2.86 | -2.38 | -3.30 | -4.46 | -19.53 | -20.99 | -23.51 | |||||
| Free Cash Flow Per Share TTM | -0.45 | -0.45 | -0.82 | -1.43 | -0.96 | -1.06 | -0.94 | -0.81 | -0.66 | -0.61 | 0.24 | -0.21 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 27.68% | 28.02% | 28.69% | 29.29% | 30.88% | 30.47% | 29.42% | 28.31% | 28.01% | 20.99% | 21.90% | 23.43% | |||||
| Operating Profit Margin TTM | -173.67% | -265.62% | -270.12% | -277.93% | -103.46% | -21.40% | -21.79% | -22.15% | -33.39% | -195.98% | -212.47% | -218.41% | |||||
| Net Profit Margin TTM | -156.41% | -251.59% | -258.44% | -265.60% | -112.71% | -29.82% | -25.63% | -31.05% | -45.29% | -203.77% | -222.89% | -231.64% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 3.82% | 0.98% | 2.31% | 4.10% | 11.22% | 18.38% | 24.76% | 25.80% | 24.65% | 16.26% | 6.08% | -0.20% | |||||
| Net Income Growth (1Y) | 44.08% | 751.96% | 931.69% | 790.42% | 176.76% | -82.68% | -85.65% | -83.14% | -81.54% | 144.03% | 181.32% | 204.67% | |||||
| EPS Growth (1Y) | 16.15% | 567.85% | 751.84% | 642.73% | 129.87% | -85.37% | -88.67% | -85.97% | -84.94% | 104.27% | 134.15% | 137.24% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.66 | -0.42 | -0.68 | -0.18 | -0.72 | -4.69 | -7.19 | -5.46 | -3.88 | -0.93 | -1.41 | -0.71 | |||||
| P/B TTM | 0.57 | 0.57 | 0.95 | 0.26 | 0.25 | 0.33 | 0.43 | 0.39 | 0.39 | 0.39 | 0.60 | 0.31 | |||||
| P/S TTM | 1.03 | 1.07 | 1.76 | 0.47 | 0.81 | 1.40 | 1.84 | 1.69 | 1.76 | 1.89 | 3.14 | 1.65 | |||||
| Market Cap | 886.76M | 893.78M | 1.46B | 382.84M | 672.17M | 1.16B | 1.50B | 1.34B | 1.31B | 1.32B | 2.05B | 1.03B | |||||
| Enterprise Value | 931.68M | 897.53M | 1.45B | 418.04M | 776.24M | 1.27B | 1.61B | 1.43B | 1.56B | 1.63B | 2.42B | 1.41B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -50.96M | -49.19M | -86.81M | -127.52M | -87.38M | -92.10M | -82.20M | -60.15M | -49.96M | -44.56M | 16.38M | -12.89M | |||||
| Net Debt | 44.92M | 3.75M | -11.91M | 35.20M | 104.07M | 115.50M | 116.94M | 93.46M | 256.71M | 310.99M | 375.41M | 373.14M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Tilray Brands, Inc. (TLRY) — SEC Financial Statements & Analysis
Tilray Brands, Inc. (TLRY) is a medicinal chemicals & botanical products company. Tilray Brands, Inc. trades on TLRY: Nasdaq as: TLRY. Based on its latest SEC filing (Form 10-Q, period ending 2026-02-28), Tilray Brands, Inc. reported a 3.82% year-over-year revenue growth, a Gross Profit Margin of 27.68% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 1.03x (TTM), a Price-to-Book (P/B) ratio of 0.57 (TTM), at a market cap of $886.76M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 3.82%
- Gross Profit Margin TTM
- 27.68%
- Debt To Equity
- 0.35x
- P/S TTM
- 1.03x
- P/B TTM
- 0.57
- Market Cap
- $886.76M
Data as of 2026-02-28 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tilray Brands, Inc. in?
Tilray Brands, Inc. (TLRY) operates in the Medicinal Chemicals & Botanical Products industry.
What is TLRY's market cap?
Tilray Brands, Inc. (TLRY) has a market capitalization of $886.76M as of 2026-02-28.
What exchange does TLRY trade on?
Tilray Brands, Inc. (TLRY) trades on the TLRY: Nasdaq.